Yorba Linda, CA, United States of America

Jason Guu

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jason Guu: Innovator in Complement Component C5 Antibodies

Introduction

Jason Guu is a notable inventor based in Yorba Linda, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to the complement pathway. With a total of three patents to his name, Guu's work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Guu's latest patents focus on complement component C5 antibodies. The first patent discusses antibodies and polynucleotides that may be used to prevent, control, or reduce the activity of the complement pathway. This patent also outlines compositions and methods for diagnosing and treating diseases mediated by or involving complement C5. The second patent reiterates similar themes, emphasizing the importance of C5 antibodies in medical applications.

Career Highlights

Throughout his career, Jason Guu has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Allergan, Inc. and Xencor, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of immunology.

Collaborations

Guu has collaborated with several professionals in his field, including Peter C Baciu and Yanbin Liang. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patents.

Conclusion

In summary, Jason Guu is a distinguished inventor whose work on complement component C5 antibodies showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of diseases related to the complement pathway.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…